BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

NMRA

Neumora Therapeutics, Inc.
Nasdaq · Biological products, (no diagnostic substances) (SIC 2836) · FY ends 31 Dec

Revenue, quarterly

—
Not reported in this company’s filings
Company filingsvpside.com

Gross margin, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com

Cash and cash equivalents, quarter-end

$117M−6.2% year on year
$400M$200M$0
Q4 ’23Q3 ’24Q1 ’25Q4 ’25Q2 ’26
Company filings · 10-Q filed 14 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com
Chart 05 is empty
Chart 06 is empty